Clinuvel Pharmaceuticals Ltd (CUV) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.050x

Based on the latest financial reports, Clinuvel Pharmaceuticals Ltd (CUV) has a cash flow conversion efficiency ratio of 0.050x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$12.52 Million ≈ $8.86 Million USD) by net assets (AU$249.02 Million ≈ $176.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Clinuvel Pharmaceuticals Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Clinuvel Pharmaceuticals Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Clinuvel Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Clinuvel Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Clinuvel Pharmaceuticals Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Miwon Commerci
KO:002840
0.074x
PAM Mineral Tbk PT
JK:NICL
0.079x
Checkpoint Therapeutics Inc
NASDAQ:CKPT
-0.717x
IGB Commercial Real Estate Investment Trust Unit
KLSE:5299
0.074x
Spear REIT Ltd
JSE:SEA
0.045x
MeguREIT Israel
TA:MGRT
0.007x
Chongqing YuXin Pingrui Electronic Co. Ltd.
SHE:301107
0.011x
Hiyes International Co Ltd
TW:2348
0.010x

Annual Cash Flow Conversion Efficiency for Clinuvel Pharmaceuticals Ltd (2001–2025)

The table below shows the annual cash flow conversion efficiency of Clinuvel Pharmaceuticals Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see Clinuvel Pharmaceuticals Ltd stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$240.81 Million
≈ $170.39 Million
AU$41.10 Million
≈ $29.08 Million
0.171x -6.50%
2024-06-30 AU$203.01 Million
≈ $143.64 Million
AU$37.05 Million
≈ $26.22 Million
0.183x -18.59%
2023-06-30 AU$164.63 Million
≈ $116.49 Million
AU$36.91 Million
≈ $26.12 Million
0.224x -29.40%
2022-06-30 AU$125.56 Million
≈ $88.84 Million
AU$39.87 Million
≈ $28.21 Million
0.318x +62.78%
2021-06-30 AU$98.74 Million
≈ $69.86 Million
AU$19.26 Million
≈ $13.63 Million
0.195x -0.91%
2020-06-30 AU$72.07 Million
≈ $50.99 Million
AU$14.19 Million
≈ $10.04 Million
0.197x -39.00%
2019-06-30 AU$57.18 Million
≈ $40.46 Million
AU$18.46 Million
≈ $13.06 Million
0.323x +8.80%
2018-06-30 AU$39.42 Million
≈ $27.89 Million
AU$11.69 Million
≈ $8.27 Million
0.297x -23.88%
2017-06-30 AU$25.44 Million
≈ $18.00 Million
AU$9.92 Million
≈ $7.02 Million
0.390x +238.00%
2016-06-30 AU$17.83 Million
≈ $12.62 Million
AU$-5.04 Million
≈ $-3.56 Million
-0.282x +30.14%
2015-06-30 AU$11.21 Million
≈ $7.93 Million
AU$-4.53 Million
≈ $-3.21 Million
-0.404x -29.70%
2014-06-30 AU$15.43 Million
≈ $10.92 Million
AU$-4.81 Million
≈ $-3.40 Million
-0.312x +37.41%
2013-06-30 AU$13.84 Million
≈ $9.79 Million
AU$-6.89 Million
≈ $-4.88 Million
-0.498x +32.24%
2012-06-30 AU$13.64 Million
≈ $9.65 Million
AU$-10.02 Million
≈ $-7.09 Million
-0.735x -27.11%
2011-06-30 AU$16.41 Million
≈ $11.61 Million
AU$-9.49 Million
≈ $-6.71 Million
-0.578x -29.67%
2010-06-30 AU$26.43 Million
≈ $18.70 Million
AU$-11.78 Million
≈ $-8.34 Million
-0.446x -50.38%
2009-06-30 AU$37.05 Million
≈ $26.22 Million
AU$-10.99 Million
≈ $-7.77 Million
-0.296x -113.93%
2008-06-30 AU$51.81 Million
≈ $36.66 Million
AU$-7.18 Million
≈ $-5.08 Million
-0.139x -10.81%
2007-06-30 AU$65.39 Million
≈ $46.27 Million
AU$-8.18 Million
≈ $-5.79 Million
-0.125x +84.66%
2006-06-30 AU$13.99 Million
≈ $9.90 Million
AU$-11.40 Million
≈ $-8.07 Million
-0.815x +34.28%
2005-06-30 AU$7.45 Million
≈ $5.27 Million
AU$-9.25 Million
≈ $-6.54 Million
-1.240x -82.98%
2004-06-30 AU$8.85 Million
≈ $6.27 Million
AU$-6.00 Million
≈ $-4.25 Million
-0.678x -180.66%
2002-06-30 AU$10.31 Million
≈ $7.29 Million
AU$-2.49 Million
≈ $-1.76 Million
-0.242x -531.42%
2001-06-30 AU$13.45 Million
≈ $9.52 Million
AU$-514.54K
≈ $-364.07K
-0.038x --

About Clinuvel Pharmaceuticals Ltd

AU:CUV Australia Biotechnology
Market Cap
$367.51 Million
AU$519.41 Million AUD
Market Cap Rank
#13943 Global
#368 in Australia
Share Price
AU$10.30
Change (1 day)
+3.73%
52-Week Range
AU$8.72 - AU$13.70
All Time High
AU$44.55
About

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with e… Read more